July 10, 2024
SAN DIEGO, CA – Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced over $277 million in Series D investment to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for years to come. The oversubscribed round was led by Wellington Management with participation from new and existing [...]
July 10, 2024
BOSTON -- CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, introduced its high-throughput Pixel™ Octo system at the International Society for Stem Cell Research (ISSCR 2024) in Hamburg, Germany. This new addition to the Pixel lineup integrates the company’s semiconductor-to-live-cell interface in an environmental controlled benchtop system to deliver live cell measurements [...]
July 10, 2024
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of [...]
Government of Canada Announces First-of-Its-Kind Biomanufacturing Facility in British Columbia
July 9, 2024
Opening of cutting-edge biomanufacturing facility creates more than 1,000 Canadian jobs, boosting the domestic life sciences sector Burnaby, British Columbia – Innovation, Science and Economic Development Canada The Government of Canada is investing in a robust, dynamic and resilient life sciences ecosystem capable of responding to current and future health emergencies. Since March 2020, over [...]
July 9, 2024
COLUMBUS, OH – GFS Chemicals, a leading supplier of high-purity specialty chemicals announced today a significant partnership with AnalytiChem Canada, a global manufacturer of products for atomic spectroscopy, inorganic sample preparation and environmental analysis. This collaboration marks a pivotal moment for both companies as they join forces to enhance product offerings and streamline accessibility for [...]
ZEISS opens new R&D and manufacturing site in Suzhou, China
July 9, 2024
Driving localization with innovation ZEISS Group's new R&D and manufacturing site in Suzhou Industrial Park officially opens, marking a milestone in ZEISS' efforts to further deepen its localization strategy in China. The significant investment enables ZEISS to respond more rapidly to local market demands while strengthening the resilience of its global R&D, manufacturing and supply [...]
Sysmex America Announces Dan Zortman as New CEO
July 9, 2024
Chicago – Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and information systems, today announced that longtime healthcare executive Dan Zortman has been named the company’s new CEO. Andy Hay, who has served as CEO since 2021, will continue to serve as Chairman and President of Sysmex America with a [...]
July 9, 2024
Accessible, highly scalable single-cell technology expands Illumina's multiomics capabilities SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. "The addition of Fluent BioSciences to Illumina will provide significant and new capabilities to [...]
Thermo Fisher Scientific Opens Its First Electron Microscopy Demo Center in Taiwan
July 9, 2024
New facility designed to support semiconductor innovation and materials R&D in one of the world’s leading technology hubs News: To support next-generation semiconductor and materials innovation, Thermo Fisher Scientific today announced the opening of its first electron microscopy demo center in Taiwan. This state-of-the-art facility, called a NanoPort, is strategically located in the region’s semiconductor [...]
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 9, 2024
Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa. -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction is expected to close in the [...]

